Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-044800
Filing Date
2023-08-07
Accepted
2023-08-07 16:14:06
Documents
1
Period of Report
2023-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4152
  Complete submission text file 0001209191-23-044800.txt   5580
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Weiss Amir (Reporting) CIK: 0001897057 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-16174 | Film No.: 231147780